Omega Therapeutics, Inc. (OMGA)
USD 0.83
(-3.2%)
USD 0.83
(-3.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -91.51 Million | -98.51 Million | -57.6 Million | -26.13 Million | -15.67 Million |
| Net Income | -97.42 Million | -102.7 Million | -68.28 Million | -29.44 Million | -17.94 Million |
| Depreciation & Amortization | 6.77 Million | 5.19 Million | 1.38 Million | 1.14 Million | 794 Thousand |
| Deferred income taxes | 1.87 Million | - | 1.33 Million | 25 Thousand | -3000.00 |
| Stock-based compensation | 8.79 Million | 7.75 Million | 3.18 Million | 637 Thousand | 335 Thousand |
| Change in working capital | -9.36 Million | -9.88 Million | 4.66 Million | 1.56 Million | 1.18 Million |
| Other non-cash items | -2.15 Million | 1.12 Million | 106 Thousand | -59 Thousand | -41 Thousand |
| Investing Cash Flow | 47.51 Million | -18.06 Million | -40.39 Million | -1.8 Million | -885 Thousand |
| Investments in PPE | -2.86 Million | -1.38 Million | -1.46 Million | -1.8 Million | -885 Thousand |
| Acquisitions | 650 Thousand | 16.68 Million | - | - | - |
| Investment purchases | -19.76 Million | -57.41 Million | -38.93 Million | - | - |
| Sales/Maturities of investments | 69.5 Million | 40.73 Million | - | - | - |
| Other Investing Activities | 50.38 Million | -16.68 Million | -38.93 Million | - | - |
| Financing Cash Flow | 41.82 Million | 708 Thousand | 261.53 Million | 48.61 Million | 11.98 Million |
| Debt repayment | -1.6 Million | - | -8 Million | - | -3.98 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 40.21 Million | 708 Thousand | 131.23 Million | 48.61 Million | 8 Million |
| Other Financing Activities | -288 Thousand | 708 Thousand | 130.3 Million | -83 Thousand | 7.97 Million |
| Accounts receivables | -5.51 Million | -362 Thousand | -257 Thousand | - | - |
| Accounts payables | -1.48 Million | 985 Thousand | 1.04 Million | 138 Thousand | 671 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | -2.36 Million | -10.5 Million | 3.87 Million | 1.42 Million | 510 Thousand |
| Cash at beginning of period | 70.61 Million | 186.82 Million | 23.29 Million | 2.61 Million | 7.19 Million |
| Cash at end of period | 68.44 Million | 70.95 Million | 186.82 Million | 23.29 Million | 2.61 Million |
| Capital Expenditure | -2.86 Million | -1.38 Million | -1.46 Million | -1.8 Million | -885 Thousand |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -2.17 Million | -115.86 Million | 163.53 Million | 20.67 Million | -4.57 Million |
| Free Cash Flow | -94.37 Million | -99.89 Million | -59.07 Million | -27.94 Million | -16.56 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.3 Million | -20.12 Million | -20.21 Million | -97.42 Million | -22.24 Million | -29.68 Million |
| Depreciation & Amortization | 613 Thousand | 1.81 Million | 1.78 Million | 6.77 Million | 1.86 Million | 1.81 Million |
| Deferred income taxes | - | - | -12.19 Million | 1.87 Million | -3000.00 | -456 Thousand |
| Stock-based compensation | 1.21 Million | 3.43 Million | 2.11 Million | 8.79 Million | 2.28 Million | 2.17 Million |
| Change in working capital | 1.79 Million | 3.06 Million | -806 Thousand | -9.36 Million | -4.95 Million | 2.86 Million |
| Other non-cash items | 1.85 Million | 2.12 Million | 12.22 Million | -2.15 Million | 23 Thousand | 11 Thousand |
| Investing Cash Flow | -396 Thousand | 4.46 Million | 2.14 Million | 47.51 Million | -724 Thousand | 24.04 Million |
| Investments in PPE | -396 Thousand | -535 Thousand | -1.11 Million | -2.86 Million | -724 Thousand | -1.03 Million |
| Acquisitions | - | - | 650 Thousand | 650 Thousand | - | - |
| Investment purchases | - | - | -3.25 Million | -19.76 Million | - | - |
| Sales/Maturities of investments | - | 5 Million | 2.6 Million | 69.5 Million | - | 25.08 Million |
| Other Investing Activities | - | 5 Million | 3.25 Million | 50.38 Million | - | 25.08 Million |
| Financing Cash Flow | -1.11 Million | -1.07 Million | 1.62 Million | 41.82 Million | -8000.00 | 219 Thousand |
| Debt repayment | -1.11 Million | -1.09 Million | -1.6 Million | -1.6 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 22 Thousand | 2000.00 | 40.21 Million | 7000.00 | 219 Thousand |
| Other Financing Activities | - | -1 Million | 15 Thousand | -288 Thousand | -15 Thousand | -152 Thousand |
| Accounts receivables | 457 Thousand | 4.98 Million | -5.73 Million | -5.51 Million | 804 Thousand | -726 Thousand |
| Accounts payables | 135 Thousand | -36 Thousand | -783 Thousand | -1.48 Million | -3.91 Million | 3.05 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.2 Million | -1.88 Million | 5.71 Million | -2.36 Million | -1.84 Million | 534 Thousand |
| Cash at beginning of period | 60.03 Million | 68.44 Million | 81.76 Million | 70.61 Million | 105.87 Million | 104.88 Million |
| Cash at end of period | 46.19 Million | 60.03 Million | 68.44 Million | 68.44 Million | 82.1 Million | 105.87 Million |
| Capital Expenditure | -396 Thousand | -535 Thousand | -1.11 Million | -2.86 Million | -724 Thousand | -1.03 Million |
| Effect of forex changes on cash | - | - | -27.23 Million | - | 26.04 Million | 1.18 Million |
| Net cash flow / Change in cash | -13.84 Million | -8.41 Million | -13.32 Million | -2.17 Million | -23.76 Million | 996 Thousand |
| Free Cash Flow | -13.06 Million | -12.34 Million | -18.2 Million | -94.37 Million | -23.76 Million | -24.3 Million |
603185
1145
CCOJY
0563
TEDE
LADR